Citicoline: Pharmacological and Clinical Review, 2010 Update

Overview

Journal Rev Neurol

Specialty Neurology

Date 2011 Mar 25

PMID 21432836

Citations 44

Authors

J J Secades

Affiliations

Soon will be listed here.

Abstract

This review is based on the previous one published in 2006 -Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 2006; 28 (Suppl B): S1-56-, incorporating the new references until now, having all the information available to facilitate the access to the informacion in one document. This review is focused on the main indications of the drug, as acute stroke and its sequelae, including the cognitive impairment, and traumatic brain injury and its sequelae. There are retrieved the most important experimental and clinical data in both indications.

Citing Articles

Update on Neuroprotection after Traumatic Brain Injury.

Cook A, Michas M, Robbins B CNS Drugs. 2025; .

PMID: 40087248 DOI: 10.1007/s40263-025-01173-9.

Can the combination of citicoline and vitamin B12 be beneficial in the healing of corneal nerves after corneal cross-linking?.

Unlu M, Ozer F, Sahin Aslan E, Sener H, Erkilic K Int Ophthalmol. 2025; 45(1):54.

PMID: 39890769 DOI: 10.1007/s10792-025-03433-5.

Potentiation of Imipramine-Induced Anti-hyperalgesic and Anti-Nociceptive Effects by Citicoline in the Sciatic Nerve Ligated Mice.

Raissi-Dehkordi N, Raissi-Dehkordi N, Hajikarimloo B, Khakpai F, Zarrindast M Arch Iran Med. 2024; 27(8):456-464.

PMID: 39306718 PMC: 11416695. DOI: 10.34172/aim.28772.

SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS....

Pannu S, Exline M, Bednash J, Englert J, Diaz P, Bartlett A Trials. 2024; 25(1):328.

PMID: 38760804 PMC: 11102211. DOI: 10.1186/s13063-024-08155-0.

Citicoline in hypoxic ischemic encephalopathy in neonates: a randomized controlled trial.

Salamah A, El Amrousy D, Elsheikh M, Mehrez M Ital J Pediatr. 2023; 49(1):55.

PMID: 37173784 PMC: 10182621. DOI: 10.1186/s13052-023-01452-5.